Serotonin syndrome: SSRIs are not the only culprit
- PMID: 34043306
- PMCID: PMC8327977
- DOI: 10.1503/jpn.210001
Serotonin syndrome: SSRIs are not the only culprit
Conflict of interest statement
R. Joober sits on the advisory boards and speakers’ bureaus of Pfizer, Janssen Ortho, BMS, Sunovion, Otsuka, Lundbeck, Perdue and Myelin; he has received grant funding from them and from AstraZeneca and HLS. He has received honoraria from Janssen Canada, Shire, Lundbeck, Otsuka, Pfizer and Perdue for CME presentations and royalties from Henry Stewart talks. He is co-editor-in-chief of JPN, but he was not involved in the review of or decision to accept this manuscript for publication. No other competing interests were declared.
References
-
- Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med 2005;352:1112–20. - PubMed
-
- Pilgrim JL, Gerostamoulos D, Drummer OH. Pharmacogenetic aspects of the effect of cytochrome P450 polymorphisms on serotonergic drug metabolism, response, interactions, and adverse effects. Forensic Sci Med Pathol 2011;7:162–84. - PubMed
-
- Rastogi R, Swarm RA, Patel TA, et al. . Case scenario: opioid association with serotonin syndrome: implications to the practitioners. Anesthesiology 2011;115: 1291–8. - PubMed
-
- Isbister GK, Buckley NA. The pathophysiology of serotonin toxicity in animals and humans: implications for diagnosis and treatment. Clin Neuropharmacol 2005; 28:205–14. - PubMed
-
- Sun-Edelstein C, Tepper SJ, Shapiro RE. Drug-induced serotonin syndrome: a review. Expert Opin Drug Saf 2008;7:587–96. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources